Get notified when BSEM files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (unchanged) — Substantial doubt exists about the company's ability to continue as a going concern for at least one year from the issuance of the financial statements.
  • Controlled-company Status (new) — Prospectus discloses controlled-company status under exchange rules, which permits exemptions from certain independent-director and committee requirements.
OTC: BSEM BioStem Technologies, Inc. S-1/A

BioStem Technologies uplists to Nasdaq; shares now trade at $4.09

Filed August 7, 2026 · Compared to S-1 Jul 29, 2026 · ~1 min read

Key Changes

  • high

    BioStem completed its uplisting from OTC to Nasdaq, with shares now trading under BSEM at $4.09 as of August 7, 2026, up from $3.35 on OTC.

    Offering verify on EDGAR →
  • medium

    The company qualifies as a controlled company under Nasdaq rules but does not intend to rely on the available corporate governance exemptions.

    Prospectus Summary verify on EDGAR →
  • medium

    Management states it has remediated a previously identified material weakness in financial reporting for 2025 and 2024.

    Risk Factors verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (WLTH 10-Q) is open in full — no account needed.

Partner

Trade BSEM commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 30, 2026 · How we verify